Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pagel

Showing results (71-80 of 245) with videos related to

Pageof 25
Sort By:
Leukemia & Lymphoma|July 26, 2016
Allogeneic hematopoietic cell transplant for patients with end stage renal disease requiring dialysis - a single institution experienceMazyar Shadman, Sangeeta Hingorani, Scott A Lanum, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 5, 2022
Outcomes for Patients With Chronic Lymphocytic Leukemia (CLL) Previously Treated With Both a Covalent BTK and BCL2 Inhibitor in the United States: A Real-World Database StudyAnthony R Mato, Lisa M Hess, Yongmei Chen, et al.
Blood|March 15, 2015
Obinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trialJennifer R Brown, Susan O'Brien, C Daniel Kingsley, et al.
Physical Chemistry Chemical Physics : PCCP|August 6, 2016
Peptides@mica: from affinity to adhesion mechanismA Gladytz, T John, T Gladytz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2012
A phase I dose-finding trial of recombinant interleukin-21 and rituximab in relapsed and refractory low grade B-cell lymphoproliferative disordersJohn M Timmerman, John C Byrd, David J Andorsky, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 2010
HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk categoryAnn Woolfrey, Stephanie J Lee, Ted A Gooley, et al.
Cancers|August 14, 2025
Overall Survival Associated with Real-World Treatment Sequences in Patients with CLL/SLL in the United StatesJoanna M Rhodes, Naleen Raj Bhandari, Manoj Khanal, et al.
Nuclear Medicine Communications|September 8, 2012
131I-tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: radiation dose to the testesNaoya Hattori, Ajay K Gopal, Andrew T Shields, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2005
Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and olderHerschel Wallen, Theodore A Gooley, H Joachim Deeg, et al.
Blood|March 25, 2006
Comparison of a tetravalent single-chain antibody-streptavidin fusion protein and an antibody-streptavidin chemical conjugate for pretargeted anti-CD20 radioimmunotherapy of B-cell lymphomasJohn M Pagel, Yukang Lin, Nathan Hedin, et al.
Pageof 25

Showing results (71-80 of 245) with videos related to

Sort By:
Pageof 25
Leukemia & Lymphoma|July 26, 2016
Allogeneic hematopoietic cell transplant for patients with end stage renal disease requiring dialysis - a single institution experienceMazyar Shadman, Sangeeta Hingorani, Scott A Lanum, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 5, 2022
Outcomes for Patients With Chronic Lymphocytic Leukemia (CLL) Previously Treated With Both a Covalent BTK and BCL2 Inhibitor in the United States: A Real-World Database StudyAnthony R Mato, Lisa M Hess, Yongmei Chen, et al.
Blood|March 15, 2015
Obinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trialJennifer R Brown, Susan O'Brien, C Daniel Kingsley, et al.
Physical Chemistry Chemical Physics : PCCP|August 6, 2016
Peptides@mica: from affinity to adhesion mechanismA Gladytz, T John, T Gladytz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2012
A phase I dose-finding trial of recombinant interleukin-21 and rituximab in relapsed and refractory low grade B-cell lymphoproliferative disordersJohn M Timmerman, John C Byrd, David J Andorsky, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 2010
HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk categoryAnn Woolfrey, Stephanie J Lee, Ted A Gooley, et al.
Cancers|August 14, 2025
Overall Survival Associated with Real-World Treatment Sequences in Patients with CLL/SLL in the United StatesJoanna M Rhodes, Naleen Raj Bhandari, Manoj Khanal, et al.
Nuclear Medicine Communications|September 8, 2012
131I-tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: radiation dose to the testesNaoya Hattori, Ajay K Gopal, Andrew T Shields, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2005
Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and olderHerschel Wallen, Theodore A Gooley, H Joachim Deeg, et al.
Blood|March 25, 2006
Comparison of a tetravalent single-chain antibody-streptavidin fusion protein and an antibody-streptavidin chemical conjugate for pretargeted anti-CD20 radioimmunotherapy of B-cell lymphomasJohn M Pagel, Yukang Lin, Nathan Hedin, et al.
Pageof 25